| | |

Breast Cancer and Mesothelioma: Case Study Illustrates Diagnostic Challenge

breast cancer and mesothelioma

A newly published Croatian case illustrates how challenging it can sometimes be to distinguish between breast cancer and mesothelioma.

The case involves a 61-year-old woman with what appeared to be breast cancer. Further study revealed that what the woman actually had was pleural mesothelioma. The mesothelioma had spread to her breast. 

Breast cancer and mesothelioma cells look similar under the microscope. But they are very different. The authors of the new report caution doctors against the “pitfall” of mistaking one for the other. 

Breast Metastasis is Rare

Pleural mesothelioma occurs on the membrane that surrounds the lungs. It is rare for mesothelioma to spread to the breast. The most common place for mesothelioma cells to spread is the lungs. 

Women are more likely to get breast cancer and mesothelioma is more common in men. Only about 0.5% to 6.6% of breast malignancies start in another part of the body. 

In addition, asbestos is the main cause of mesothelioma. It was mostly used in male-dominated industries like construction. 

These are all reasons why doctors may not think about mesothelioma when they find cancer in a woman’s breast. But that oversight can be costly. 

“The epithelioid type of MPM can represent a diagnostic pitfall in this setting,” writes lead author Lea Korša, of University Hospital Centre Zagreb. “It shows similar histologic features to primary breast carcinoma as well as other metastatic epithelioid malignancies.” 

Distinguishing Between Breast Cancer and Mesothelioma

Why does it matter whether doctors distinguish between breast cancer and mesothelioma? Because the two types of cancer have different treatments. They also carry different prognoses.

Malignant mesothelioma is one of the rarest and most difficult cancers to treat. Primary breast cancer usually responds well to chemotherapy and radiation. But mesothelioma is often resistant to both. Many patients die within a year of a mesothelioma diagnosis. 

One of the main ways to tell the difference between primary breast cancer and mesothelioma in the breast is through patient history. 

If a patient worked around asbestos, they could have mesothelioma. Smoking increases the risk. If doctors have this information about patients, they are less likely to miss metastatic mesothelioma in the breast. 

Italian researchers published a similar case study in 2015. In that case, a 49-year-old hairdresser had a large mass in her right breast. 

Doctors ruled out breast cancer and mesothelioma was diagnosed after estrogen and progesterone receptors were negative. The woman probably inhaled asbestos fibers from working with asbestos-containing hairdryers. 

Source:

Korsa, L, et al, “Breast Metastasis as the Initial Presentation of Malignant Pleural Mesothelioma”, May 30, 2020, The Breast Journal, Epub ahead of print, https://onlinelibrary.wiley.com/doi/abs/10.1111/tbj.13898

Framarino-Dei-Malatesta, M, et al, “Breast cancer or metastasis? An unusual case of metastatic malignant pleural mesothelioma to the breast”, February 25, 2015, World Journal of Surgical Oncology, Epub ahead of print

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…